Imagining the Future of Personalized Medicine
Sunday, March 13
3:30PM - 4:30PM
110 E 2nd St
2015 was a banner year for digital health with over $4B in funding, yet most goes to serve the ‘worried well’. It’s time to reach higher and start solving the harder problems in healthcare. But how? Through wearables and apps that help us change our behaviors? Through smarter drug delivery that harnesses the power of big data and artificial intelligence? Or is there a hybrid yet to be imagined? David O'Reilly, leader in digital medicine, and Jenny Hapgood, behavior change product designer, discuss the best path forward toward more engaging and personalized healthcare and lay out future possibilities that will astound you.
Chief Prod Officer
Proteus Digital Health
David O'Reilly is Chief Product Officer of Proteus Digital Health, a San Francisco Bay Area company that has created a new category of therapy: Digital Medicine. David leads the company's product d...Show the rest
David O'Reilly is Chief Product Officer of Proteus Digital Health, a San Francisco Bay Area company that has created a new category of therapy: Digital Medicine. David leads the company's product development, business development and corporate strategy. Prior to joining Proteus, David was President of Catalyst Biosciences, a company developing novel therapeutic protein products, and Chief Business Officer and member of the founding management team at Iconix Biosciences (acquired by Entelos), a genomic biomarker company. David is a graduate of Wesleyan University and Harvard Business School, where he received an M.B.A. with Distinction.Hide the rest
VP Prod Mgmt & Mktg
Ms. Hapgood is Vice President of Product Management & Marketing at Chrono Therapeutics, a speciality pharma company developing a medication delivery wearable integrated with digital behavioral supp...Show the rest
Ms. Hapgood is Vice President of Product Management & Marketing at Chrono Therapeutics, a speciality pharma company developing a medication delivery wearable integrated with digital behavioral support.
Ms. Hapgood has more than ten year’s experience designing and launching behavior change, wellness, and digital coaching services with the goal of driving meaningful health outcomes and customer engagement. Prior to joining Chrono Therapeutics, she was Vice President of Product Management at Free & Clear (acquired by Alere, Inc.), the largest provider of tobacco cessation coaching in the country. While there, Ms. Hapgood managed the product strategy for the company’s cessation and wellness products, shipping dozens of behavior change solutions across web, mobile, and desktop platforms.
Ms. Hapgood holds a ScM in Health & Behavior Change from Harvard University and a BA in English from Davidson College.Hide the rest